NCT03588026Phase 3Completed

Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576

Study sponsor: AKARI Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2020-09-03Actual
Enrollment · participants9Actual
Source updated2025-04-09Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.